drugset / Trial / NCT00027079

Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)

NCT00027079

RandomizedDouble-blindTreatment

Summary

This study will compare the effectiveness of ondansetron (Zofran) and naltrexone (ReVia) both alone and in combination in treating Early Onset Alcoholics versus Late Onset Alcoholics. All subjects will received standardized Cognitive Behavioral Therapy. Followup assessments will be completed at 1, 3, 6, and 9 months after treatment.

Timeline

Start
2001-09
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule
Subject Ondansetron Other / unclassified

Indications